Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1009 | Thyroid (non-cancer) | ECE2014

Severe side effects of methimazole in the treatment of hyperthyroidism

Moreno Carolina , Alves Marcia , Paiva Isabel , Rodrigues Dircea , Ruas Luisa , Saraiva Joana , Guelho Daniela , Vicente Nuno , Cardoso Luis , Carrilho Francisco

Introduction: Methimazole is the thionamide compound most used in the treatment of hyperthyroidism due to its efficacy, commodity and security. Severe side effects are rare, although potentially fatal: agranulocytosis in 0.1–0.5% and toxic hepatitis in 0.1%Aims: To characterize the patients admitted in the endocrinology ward for the last 10 years for severe complications of methimazole therapy.Material and Methods: Retrospecti...

ea0063p728 | Pituitary and Neuroendocrinology 2 | ECE2019

Acromegaly in McCune-Albright Syndrome: case report

Reis Guiomar Joana , Moreno Carolina , Paiva Isabel , Miguel Cardoso Luis , Cunha Nelson , Catarino Diana , Fadiga Lucia , Festas Silva Diana , Pedro Freitas Joao , Bastos Margarida

Introduction: McCune-Albright syndrome (MAS) consists of at least two of the following three conditions: polyostotic fibrous dysplasia (PFD), café-au-lait skin pigmentation and autonomous endocrine hyperfunction. The most common form of autonomous endocrine hyperfunction is precocious puberty, but other syndromes may be present, including acromegaly, hyperthyroidism, and Cushing syndrome. Acromegaly is seen in approximately 20% of patients with MAS. Treatment opt...

ea0063p929 | Diabetes, Obesity and Metabolism 3 | ECE2019

Idiopathic versus autoimmune type 1 diabetes – long-term differences

Catarino Diana , Silva Diana , Pereira Claudia , Ribeiro Cristina , Ruas Luisa , Cunha Nelson , Fadiga Lucia , Guiomar Joana , Lavrador Mariana , Vieira Ines , Cardoso Luis , Paiva Isabel , Bastos Margarida

Introduction: The American Diabetes Association proposed two subcategories for type 1 diabetes: autoimmune type 1 diabetes (ADM) and idiopathic type 1 diabetes (IDM). The absence of β-cell autoimmune markers and lack of association with HLA haplotypes define the second category, whose pathogenesis remains unclear. Only a minority of patients with type 1 diabetes fall into this subcategory which is considered by several authors similar to type 2 diabetes.<p class="abst...

ea0063p947 | Diabetes, Obesity and Metabolism 3 | ECE2019

Autoimmune diabetes mellitus versus idiopathic: differences at diagnosis

Silva Diana , Catarino Diana , Pereira Claudia , Ruas Luisa , Ribeiro Cristina , Cunha Nelson , Fadiga Lucia , Guiomar Joana , Cardoso Luis , Paiva Isabel , Carrilho Francisco

Introduction: The American Diabetes Association proposed two categories for the classification of type 1 diabetes mellitus (DM): autoimmune (AI) and idiopathic (ID). The absence of autoimmune markers or association with HLA haplotypes defines the second category. Only a small minority of patients with type 1 diabetes fall into this category.Objective: To evaluate the clinical characteristics of both categories and to analyze the differe...

ea0049ep392 | Clinical case reports - Thyroid/Others | ECE2017

Continuous glucose monitoring in glycogen storage disease type Ia – a major improvement for patients

Martins Diana , Oliveira Diana , Baptista Carla , Paiva Sandra , Vicente Nuno , Cardoso Luis , Lages Adriana , Ventura Mara , Cunha Nelson , Moreira Sonia , Clemente Hugo , Esperto Helder , Carrilho Francisco

Introduction: Glycogen storage disease (GSD) type Ia (von Gierke’s disease) is an inherited metabolic disorder of glycogen metabolism, caused by defects in the glucose-6-phosphatase complex, with associated risk of severe hypoglycemia within 3–4 h after a meal.The aim of the present study was to evaluate the efficacy of continuous glucose monitoring (CGM) system in determining the magnitude of hypoglycemia in patients with GSD type Ia.<p cl...

ea0041gp60 | Clinical Case Reports | ECE2016

Endoscopic ultrasound-guided ethanol ablation therapy for pancreatic insulinoma: an unusual strategy

Lages Adriana de Sousa , Oliveira Patricia , Paiva Isabel , Portela Francisco , Guelho Daniela , Cardoso Luis , Vicente Nuno , Oliveira Diana , Martins Diana , Ventura Mara , Carrilho Francisco

Introduction: Insulinomas are the most frequent cause of endogenous hypoglycaemia. 90 to 95% of these are benign. Surgical enucleation or resection is the standard treatment. Medical therapy focuses mainly on the use of diazoxide with few alternatives in patients with high surgical risk.Case-report: Female patient, 89 years-old, non-diabetic, with previous history of acute myocardial infarction, stroke with motor sequelae, pacemaker carrier and severe ao...

ea0041gp92 | Diabetes (2) | ECE2016

The effect of glucose variability on microvascular complications in type 1 diabetes

Cardoso Luis , Baptista Carla , Rodrigues Dircea , Barros Luisa , Guelho Daniela , Vicente Nuno , Martins Diana , Oliveira Diana , Lages Adriana , Ventura Mara , Carrilho Francisco

Introduction: Evidence implicates oxidative stress as mediator of diabetic complications. Furthermore, glucose variability (GV) is associated with oxidative stress and inflammation; however, association between GV and diabetes complications remains to be established. Our aim was to assess GV in patients with and without microvascular complications (MVC).Methods: We analysed 2454 and 6593 h of continuous glucose monitoring of patients with type 1 diabetes...

ea0041gp207 | Thyroid - Translational &amp; Clinical | ECE2016

Predictive factors of outcomes in radioiodine treatment for Graves’ disease

Cardoso Luis , Rodrigues Dircea , Silva Monica , Vicente Nuno , Guelho Daniela , Martins Diana , Oliveira Diana , Lages Adriana , Ventura Mara , Costa Gracinda , Pedroso Lima Joao , Carrilho Francisco

Introduction: Radioiodine (131I, RAI) is a safe and effective option for the treatment of Graves’ disease (GD). However, approximately 20% of RAI treated patients will have persistent disease or will relapse after the first treatment. Our aim was to identify the factors influencing the outcomes in RAI treatment for GD.Methods: We analysed 143 DG patients (116 women) treated with RAI between October 2002 and April 2014 and ≥12 months...

ea0041ep60 | Adrenal cortex (to include Cushing's) | ECE2016

Primary hyperaldosteronism: clinical and therapeutic approach of a center

Martins Diana , Moreno Carolina , Baptista Carla , Paiva Isabel , Guelho Daniela , Vicente Nuno , Cardoso Luis , Oliveira Diana , Lages Adriana , Ventura Mara , Carrilho Francisco

Introduction: Primary hyperaldosteronism (HAP) is the main cause of secondary hypertension, with a prevalence estimated between 6 and 20% in resistant hypertension. Clinical suspicion is critical, especially if aldosterone-to-renin ratio (ARR) >25, however the diagnosis is dependent on confirmatory evidence, including aldosterone suppression tests.Methods: Retrospective evaluation of 44 patients with suspected PAH, identified betwee...

ea0041ep121 | Bone &amp; Osteoporosis | ECE2016

Anorexia nervosa: beyond psychiatry

Vicente Nuno , Rodrigues Dirceaj , Barros Luisa , Guelho Daniela , Cardoso Luis , Martins Diana , Oliveira Diana , Lages Adriana , Ventura Mara , Fonseca Ligia , Figueiredo Julia , Carrilho Francisco

Introduction: Despite being a psychiatric disorder, anorexia nervosa (AN) is associated to severe systemic complications. The endocrine complications of AN are an opportunity for the diagnosis and treatment of this condition. The authors report the experience of the Endocrinology Department in the treatment of AN in inpatient setting.Patients and methods: Retrospective analysis of 45 patients admitted with AN between 2001 and 2015 in the Endocrinology de...